China’s Jiangsu Hansoh Pharmaceutical Plans up to $3 Billion Hong Kong IPO – Wall Street Journal


Wall Street Journal
China’s Jiangsu Hansoh Pharmaceutical Plans up to $3 Billion Hong Kong IPO
Wall Street Journal
A large Chinese pharmaceutical company is planning to raise up to $3 billion in a Hong Kong initial public offering later this year, tapping demand to invest in China’s growing health-care market, according to people familiar with the matter. Jiangsu

and moreĀ >>

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd